Nanotechnological Strategies for the Treatment of Neglected Diseases

Author(s): Najeh Maissar Khalil, Ana Cristina de Mattos, Talita Cristina Moraes Moreira Carraro, Daniel Brustolin Ludwig, Rubiana Mara Mainardes

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 41 , 2013

Become EABM
Become Reviewer
Call for Editor


Neglected diseases are prevalent in less developed countries and are associated with high levels of mortality and/or morbidity. The drugs used in clinical practice are toxic, reducing patient compliance, and generally do not result in a cure, and there has also been a surge in drug resistance. Additionally, a major challenge in drug treatment lies in reaching the intracellular sites infected by parasites. The development of nanotechnology-based drug delivery systems for drugs intended to treat neglected diseases is a promising avenue because the use of nanocarriers presents the ability to target drugs to the infected cells, and the prolonged drug release profile possible with these systems permits longer contact between the drug and the parasite. This review describes the roles of colloidal drug carriers, such as liposomes, polymeric nanoparticles and solid lipid nanoparticles, in research on optimizing the delivery of antileishmanial, antitrypanosomal, antichagasic and antimalarial agents.

Keywords: Chagas disease, leishmaniasis, liposomes, malaria, nanoparticles, schistosomiasis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 19 December, 2013
Page: [7316 - 7329]
Pages: 14
DOI: 10.2174/138161281941131219135458
Price: $65

Article Metrics

PDF: 23